Medicine - Hematology and Medical Oncology

Research output

Research output per year 1949 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

• 295022 Citations
• 233 h-index
• 4032 Article
• 685 Review article
• 251 Letter
• 203 Comment/debate
• 303 More
  • 131 Chapter
  • 100 Editorial
  • 41 Short survey
  • 12 Conference contribution
  • 6 Foreword/postscript
  • 5 Book
  • 5 Paper
  • 3 Conference article

Research output per year

Research output per year

Search results

• 2023

  Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS

  Moreau, P., Chari, A., Oriol, A., Martinez-Lopez, J., Haenel, M., Touzeau, C., Ailawadhi, S., Besemer, B., de la Rubia Comos, J., Encinas, C., Mateos, M. V., Salwender, H., Rodriguez-Otero, P., Hulin, C., Karlin, L., Sureda Balari, A., Bargay, J., Benboubker, L., Rosiñol, L., Tarantolo, S., & 8 othersTerebelo, H., Yang, S., Wang, J., Nnane, I., Qi, M., Kosh, M., Delioukina, M. & Goldschmidt, H., 7 Mar 2023, In: Blood Cancer Journal. 13, 1, p. 33 1 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Techniques for Clinical Practice: Communication Strategies for Black Patients with Serious Illness

  Frydman, J. L., Arnold, R. M., Gelfman, L. P. & Smith, C. B., Jan 2023, In: Journal of Pain and Symptom Management. 65, 1, p. e105-e107

  Research output: Contribution to journal › Letter › peer-review
• 2022

  Are all licensed haemostatic agents for haemophilia therapy accessible to patients?

  the International Prophylaxis Study Group, Nov 2022, In: Haemophilia. 28, 6, p. e256-e258

  Research output: Contribution to journal › Letter › peer-review

• Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients

  PVI/MM/Seronet Study Group, 9 May 2022, In: Cancer Cell. 40, 5, p. 441-443 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  12 Scopus citations

• Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN

  Nooka, A. K., Kaufman, J. L., Rodriguez, C., Jakubowiak, A., Efebera, Y., Reeves, B., Wildes, T., Holstein, S. A., Anderson, L. D., Badros, A., Shune, L., Chari, A., Pei, H., Cortoos, A., Patel, S., Bartlett, J. B., Vermeulen, J., Lin, T. S., Richardson, P. G. & Voorhees, P., Apr 2022, In: Blood Cancer Journal. 12, 4, 63.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  1 Scopus citations

• European LeukemiaNet Response Predicts Disease Progression but Not Thrombosis in Polycythemia Vera

  Tremblay, D., Srisuwananukorn, A., Ronner, L., Podoltsev, N., Gotlib, J., Heaney, M. L., Kuykendall, A., O'Connell, C. L., Shammo, J. M., Fleischman, A., Mesa, R., Yacoub, A., Hoffman, R., Moshier, E., Zubizarreta, N. & Mascarenhas, J., 11 Jun 2022, In: HemaSphere. 6, 6, p. E721

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  2 Scopus citations

• Extracellular vesicles for early detection of hepatocellular carcinoma

  Losic, B. & Villanueva, A., Aug 2022, In: ExRNA. 4, 19.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Lessons learned from early closure of a clinical trial for steroid-refractory acute GVHD

  Meyers, G., Hamadani, M., Martens, M., Ali, H., Choe, H., Dawson, P., Harris, A. C., van Hooren, E., Klaassen, W., Leifer, E., MacMillan, M. L., van Oosterhout, Y., Perez, L., Pusic, I., Vo, P. & Levine, J. E., Feb 2022, In: Bone Marrow Transplantation. 57, 2, p. 302-303 2 p.

  Research output: Contribution to journal › Letter › peer-review

• Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer

  PARIS/PSP study group, 13 Jun 2022, In: Cancer Cell. 40, 6, p. 575-577 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  3 Scopus citations

• Neoadjuvant immunotherapy for resectable hepatocellular carcinoma – Authors' reply

  Marron, T. U., Schwartz, M. E., Miller, E., Thanigaimani, P., Lowy, I., Thurston, G. & Merad, M., Jun 2022, In: The Lancet Gastroenterology and Hepatology. 7, 6, p. 505 1 p.

  Research output: Contribution to journal › Letter › peer-review

• Patient-generated strategies for strengthening adherence to multiple medication regimens after allogeneic stem cell transplantation: a qualitative study

  Song, Y., Chen, S., Roseman, J., Scigliano, E., Allegrante, J. P. & Stadler, G., Sep 2022, In: Bone Marrow Transplantation. 57, 9, p. 1455-1457 3 p.

  Research output: Contribution to journal › Letter › peer-review

• Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis

  Rosenbaum, C. A., Özbek, U., Sanchez, L., Lagdameo, J., Abrahams, A., Hassoun, H., Lahoud, O., Niesvizky, R., Landau, H. J. & Osman, K., 27 Sep 2022, In: Blood advances. 6, 18, p. 5436-5439 4 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• SARS-CoV-2 infection associated with aplastic anemia and pure red cell aplasia

  Lee, N. C. J., Patel, B., Etra, A., Bat, T., Ibrahim, I. F., Vusirikala, M., Chen, M., Rosado, F., Jaso, J. M., Young, N. S. & Chen, W., 12 Jul 2022, In: Blood advances. 6, 13, p. 3840-3843 4 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  1 Scopus citations

• Self-reported Transportation Barriers to Health Care among US Cancer Survivors

  Jiang, C., Yabroff, K. R., Deng, L., Wang, Q., Perimbeti, S., Shapiro, C. L. & Han, X., May 2022, In: JAMA Oncology. 8, 5, p. 775-778 4 p.

  Research output: Contribution to journal › Letter › peer-review
  8 Scopus citations

• Treatment of Hepatocellular Carcinoma with Neoadjuvant Nivolumab Alone Versus in Combination with a CCR2/5 Inhibitor or an Anti-IL-8 Antibody

  Rossi, A. J., Khan, T. M., Saif, A., Marron, T. U. & Hernandez, J. M., Jan 2022, In: Annals of Surgical Oncology. 29, 1, p. 30-32 3 p.

  Research output: Contribution to journal › Letter › peer-review
• 2021

  Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma. Reply

  Bajorin, D. F., Collette, S. & Galsky, M. D., 2 Sep 2021, In: New England Journal of Medicine. 385, 10, p. 957 1 p.

  Research output: Contribution to journal › Letter › peer-review

• A phase 1b dose-escalation/expansion study of BET inhibitor RO6870810 in patients with advanced multiple myeloma

  Ramasamy, K., Nooka, A., Quach, H., Htut, M., Popat, R., Liedtke, M., Tuchman, S. A., Laubach, J., Gasparetto, C., Chanan-Khan, A., Hertzberg, M., deMario, M., Nueesch, E., Chesne, E., Franjkovic, I., Lechner, K., Kornacker, M. & Cho, H. J., Sep 2021, In: Blood Cancer Journal. 11, 9, 149.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  4 Scopus citations

• Central Nervous System Hemophagocytic Lymphohistiocytosis (CNS-HLH) from Leptomeningeal Anaplastic Large Cell Lymphoma: Mild Clinical Neurologic Syndrome with Extensive Multifocal White Matter Disease

  Lehrer, H., Scigliano, E. & Chan, A., Sep 2021, In: Clinical Neuroradiology. 31, 3, p. 881-883 3 p.

  Research output: Contribution to journal › Letter › peer-review

• Comment on “Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis”

  Tremblay, D., Mascarenhas, J., Schiano, T. & Naymagon, L., Jan 2021, In: Journal of Hepatology. 74, 1, p. 249-250 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Comparison of post-transplant vaccination among allogeneic and autologous hematopoietic stem cell transplant patients: a single center quality analysis

  Puliafito, B., Zhao, Y., Afshar, S., Galitzeck, Z. & Steinberg, A., Jul 2021, In: Bone Marrow Transplantation. 56, 7, p. 1717-1719 3 p.

  Research output: Contribution to journal › Letter › peer-review

• Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma

  Mateos, M. V., Gavriatopoulou, M., Facon, T., Auner, H. W., Leleu, X., Hájek, R., Dimopoulos, M. A., Delimpasi, S., Simonova, M., Špička, I., Pour, L., Kriachok, I., Pylypenko, H., Doronin, V., Usenko, G., Benjamin, R., Dolai, T. K., Sinha, D. K., Venner, C. P., Garg, M., & 17 othersStevens, D. A., Quach, H., Jagannath, S., Moreau, P., Levy, M., Badros, A. Z., Anderson, L. D., Bahlis, N. J., Cavo, M., Chai, Y., Jeha, J., Arazy, M., Shah, J., Shacham, S., Kauffman, M. G., Richardson, P. G. & Grosicki, S., Dec 2021, In: Journal of Hematology and Oncology. 14, 1, 59.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

  • selinexor 100%
  • Bortezomib 66%
  • Multiple Myeloma 53%
  • Dexamethasone 49%
  • Peripheral Nervous System Diseases 25%
  8 Scopus citations

• Hepatocellular carcinoma in obliterative portal venopathy

  El Homsi, M., Isabel Fiel, M. & Taouli, B., Feb 2021, In: Diagnostic and interventional imaging. 102, 2, p. 115-116 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  1 Scopus citations

• Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma

  PVI/Seronet team, 9 Aug 2021, In: Cancer Cell. 39, 8, p. 1028-1030 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  115 Scopus citations

• In response to WFH guidelines for the management of haemophilia, 3^rd edition: Is there a difference between extended-half-life FVIII products or not?

  Berntorp, E., Krassova, S. & Aledort, L., Nov 2021, In: Haemophilia. 27, 6, p. e762-e764

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkers

  Kasikis, S., Baez, J., Gandhi, I., Grupp, S., Kitko, C. L., Kowalyk, S., Merli, P., Morales, G., Pulsipher, M. A., Qayed, M., Wölfl, M., Yanik, G., See, F., Hayes, J., Grossman, F., Burke, E., Young, R., Levine, J. E. & Ferrara, J. L. M., Nov 2021, In: Bone Marrow Transplantation. 56, 11, p. 2869-2870 2 p.

  Research output: Contribution to journal › Letter › peer-review
  3 Scopus citations

• Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH

  Cornell, R., Hari, P., Tang, S., Biran, N., Callander, N., Chari, A., Chhabra, S., Fiala, M. A., Gahvari, Z., Gandhi, U., Godby, K., Gupta, R., Jagannath, S., Jagosky, M., Kang, Y., Kansagra, A., Kauffman, M., Kodali, S., Kumar, S. K., Lakshman, A., & 18 othersLiedtke, M., Lonial, S., Ma, X., Malek, E., Mansour, J., McGehee, E. F., Neppalli, A., Paul, B., Richardson, P., Scott, E. C., Shacham, S., Shah, J., Siegel, D. S., Umyarova, E., Usmani, S. Z., Varnado, W., Vij, R. & Costa, L., Jan 2021, In: American Journal of Hematology. 96, 1, p. E5-E8

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  14 Scopus citations

• Pembrolizumab, lenalidomide and dexamethasone post autologous transplant in patients with high-risk multiple myeloma

  Biran, N., Gourna Paleoudis, E., Feinman, R., Vesole, D. H., Zenreich, J., Wang, S., Ahn, J., Bansal, M., Rowley, S., Donato, M., Pecora, A. L., Richter, J., Anand, P., McBride, L., Ivanovski, K., Korngold, R. & Siegel, D. S., 1 Nov 2021, In: American Journal of Hematology. 96, 11, p. E430-E433

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  1 Scopus citations

• Peripheral neuropathy symptoms, pain, and functioning in previously treated multiple myeloma patients treated with selinexor, bortezomib, and dexamethasone

  Sanchez, L., Leleu, X., Beaumont, J. L., Yu, H., Hudgens, S., Simonova, M., Auner, H. W., Quach, H., Delimpasi, S., Špička, I., Pour, L., Kriachok, I., Dimopoulos, M. A., Usenko, G., Hájek, R., Benjamin, R., Sinha, D. K., Venner, C., Illmer, T., Garg, M. K., & 16 othersStevens, D. A., Jagannath, S., Levy, M., Anderson, L. D., Bahlis, N. J., Facon, T., Cavo, M., Chai, Y., Ma, X., Tang, S., Leong, H., Shah, J., Shacham, S., Kauffman, M., Richardson, P. & Grosicki, S., 1 Oct 2021, In: American Journal of Hematology. 96, 10, p. E383-E386

  Research output: Contribution to journal › Letter › peer-review
  3 Scopus citations

• Prevalence of unexplained erythrocytosis and thrombocytosis–an NHANES analysis

  Tremblay, D., Alpert, N., Taioli, E. & Mascarenhas, J., 2021, In: Leukemia and Lymphoma. 62, 8, p. 2030-2033 4 p.

  Research output: Contribution to journal › Letter › peer-review
  2 Scopus citations

• Red cell distribution width is associated with mortality in non-anemic patients with COVID-19

  Rapp, J. L., Tremblay, D., Alpert, N., Lieberman-Cribbin, W., Mascarenhas, J., Taioli, E. & Ghaffari, S., Jul 2021, In: Journal of Medical Virology. 93, 7, p. 4130-4132 3 p.

  Research output: Contribution to journal › Letter › peer-review
  6 Scopus citations

• Selinexor, bortezomib, and dexamethasone (SVD) in heavily treated relapsed refractory multiple myeloma

  Mouhieddine, T. H., Parekh, S., Cho, H. J., Richter, J., DeCastro, A., Shah, J., Landesman, Y., Chari, A., Jagannath, S. & Madduri, D., Dec 2021, In: Annals of Hematology. 100, 12, p. 3057-3060 4 p.

  Research output: Contribution to journal › Letter › peer-review
  2 Scopus citations

• Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect^® MM Registry

  Connect® MM Registry, Jul 2021, In: Blood Cancer Journal. 11, 7, 134.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  1 Scopus citations

• Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma

  PVI/Seronet Study Group, 8 Nov 2021, In: Cancer Cell. 39, 11, p. 1442-1444 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  34 Scopus citations
• 2020

  Acute kidney injury after ruxolitinib: Common complication, uncommon cause

  Strohbehn, S., Seethapathy, H., Rusibamayila, N., Strohbehn, I., Lee, M., Hobbs, G., Keyzner, A., Jhaveri, K. D. & Sise, M. E., 1 Jul 2020, In: American Journal of Hematology. 95, 7, p. E181-E183

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  1 Scopus citations

• An Opportunity for Hospice Referral in Acute Myeloid Leukemia: Prognostic Significance of Hospitalization Status at Time of Second Cycle of Hypomethylating Agents for Patients Ineligible for Intensive Induction Chemotherapy

  Tremblay, D., Madero-Marroquin, R., Lancman, G., Coltoff, A., Feld, J., Caro, J., Sherlock, E., Keyzner, A., Navada, S., Silverman, L. R., Moshier, E., Zubizarreta, N. & Mascarenhas, J., Nov 2020, In: Journal of Palliative Medicine. 23, 11, p. 1424-1425 2 p.

  Research output: Contribution to journal › Letter › peer-review

• Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study

  Schmidt, A. L., Bakouny, Z., Bhalla, S., Steinharter, J. A., Tremblay, D. A., Awad, M. M., Kessler, A. J., Haddad, R. I., Evans, M., Busser, F., Wotman, M., Curran, C. R., Zimmerman, B. S., Bouchard, G., Jun, T., Nuzzo, P. V., Qin, Q., Hirsch, L., Feld, J., Kelleher, K. M., & 9 othersSeidman, D., Huang, H. H., Anderson-Keightly, H. M., Abou Alaiwi, S., Rosenbloom, T. D., Stewart, P. S., Galsky, M. D., Choueiri, T. K. & Doroshow, D. B., 14 Dec 2020, In: Cancer Cell. 38, 6, p. 769-770 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  34 Scopus citations

• COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter

  Varma, A., Kosuri, S., Ustun, C., Ibrahim, U., Moreira, J., Bishop, M. R., Nathan, S., Mehta, J., Moncayo, D., Heng, J., Osman, K. & Adekola, K. U. A., 1 Oct 2020, In: Leukemia. 34, 10, p. 2809-2812 4 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  32 Scopus citations

• Does androgen deprivation therapy protect against severe complications from COVID-19?

  Patel, V. G., Zhong, X., Liaw, B., Tremblay, D., Tsao, C. K., Galsky, M. D. & Oh, W. K., Oct 2020, In: Annals of Oncology. 31, 10, p. 1419-1420 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  55 Scopus citations

• Emicizumab in Hemophilia A. Reply

  Aledort, L. M., 20 Feb 2020, In: New England Journal of Medicine. 382, 8, p. 786 1 p.

  Research output: Contribution to journal › Letter › peer-review

• Genomic analysis of metastatic melanoma in an adult with giant congenital melanocytic nevus

  Chang, L. W., Iqbal, R., Badal, B., Bernstein, D., Mendelson, K., Solovyov, A., Friedlander, P., Phelps, R., Goodheart, H., Desman, G., Greenbaum, B. D. & Tok Celebi, J., 1 Jul 2020, In: Pigment Cell and Melanoma Research. 33, 4, p. 633-636 4 p.

  Research output: Contribution to journal › Letter › peer-review
  1 Scopus citations

• Magnetic resonance elastography vs. point shear wave ultrasound elastography for the assessment of renal allograft dysfunction

  Kennedy, P., Bane, O., Hectors, S. J., Gordic, S., Berger, M., Delaney, V., Salem, F., Lewis, S., Menon, M. & Taouli, B., Sep 2020, In: European Journal of Radiology. 130, 109180.

  Research output: Contribution to journal › Letter › peer-review
  3 Scopus citations

• Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience

  Tremblay, D., Vogel, A. S., Moshier, E., Hoffman, R., Kremyanskaya, M., Zhou, S., Schiano, T. & Mascarenhas, J., 1 Jan 2020, In: European Journal of Haematology. 104, 1, p. 72-73 2 p.

  Research output: Contribution to journal › Letter › peer-review
  8 Scopus citations

• PD-1 inhibitors for urothelial cancer: combination or sequential therapy? – Authors' reply

  Galsky, M. D. & Grande, E., 19 Dec 2020, In: The Lancet. 396, 10267, p. 1977-1978 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Re: Exposure to asbestos and the risk of colorectal cancer mortality: A systematic review and meta-analysis by Kwak et al

  Boffetta, P., 1 Sep 2020, In: Occupational and Environmental Medicine. 77, 9, p. 655 1 p.

  Research output: Contribution to journal › Letter › peer-review

• Recapturing disease response: A phase 2 study of carfilzomib 56 mg/m² in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27 mg/m²

  Barley, K., Sanchez, L., Cho, H. J., Parekh, S., Madduri, D., Richter, J., Isola, L., Goldstein, T., Dhadwal, A., Zarychta, K., Sanchez, G. M., Catamero, D., Verina, D., Florendo, E., Yum, M. H., La, L., Gullie, J., Chan, E., Jagannath, S. & Chari, A., 1 Feb 2020, In: American Journal of Hematology. 95, 2, p. E51-E54

  Research output: Contribution to journal › Letter › peer-review

• Reply to E. Gonzalez-Rodriguez et al

  Shapiro, C. L., Lacchetti, C. & Neuner, J., 10 May 2020, In: Journal of Clinical Oncology. 38, 14, p. 1642-1643 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Sampling the host response to SARS-CoV-2 in hospitals under siege

  The Mount Sinai COVID-19 Biobank Team, 1 Aug 2020, In: Nature Medicine. 26, 8, p. 1157-1158 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  9 Scopus citations

• Selinexor-based regimens for the treatment of myeloma refractory to chimeric antigen receptor T cell therapy

  Chari, A., Vogl, D. T., Jagannath, S., Jasielec, J., Unger, T. J., DeCastro, A., Shah, J., Kauffman, M., Shacham, S. & Jakubowiak, A., 1 May 2020, In: British Journal of Haematology. 189, 4, p. e126-e130

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  7 Scopus citations

• SF3B1 mutations induce R-loop accumulation and DNA damage in MDS and leukemia cells with therapeutic implications

  Singh, S., Ahmed, D., Dolatshad, H., Tatwavedi, D., Schulze, U., Sanchi, A., Ryley, S., Dhir, A., Carpenter, L., Watt, S. M., Roberts, D. J., Abdel-Aal, A. M., Sayed, S. K., Mohamed, S. A., Schuh, A., Vyas, P., Killick, S., Kotini, A. G., Papapetrou, E. P., Wiseman, D. H., & 2 othersPellagatti, A. & Boultwood, J., 1 Sep 2020, In: Leukemia. 34, 9, p. 2525-2530 6 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  30 Scopus citations

• The effect of radiation therapy on the objective response and outcomes with nivolumab for hepatocellular carcinoma

  Smith, W. H., Law, A. S., Hulkower, M., McGee, H. M., Lehrer, E. J., Schwartz, M., Taouli, B., Sung, M. & Buckstein, M., 2 Aug 2020, In: Acta Oncologica. 59, 8, p. 940-943 4 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  2 Scopus citations